StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Trioxysalen

Trimethylpsoralen

HCID 5585
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
3902-71-4
Standard-SMILES
Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
Summenformel
C14H12O3
Durchschnittliche Molmasse
228,24 g/mol
Monoisotopische Masse
228,07864424

Überblick

Trioxsalen is 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis. It has a role as a photosensitizing agent and a dermatologic drug.

Namen und Bezeichner

Bevorzugter Name
Trimethylpsoralen
IUPAC
2,5,9-trimethylfuro[3,2-g]chromen-7-one
Lokaler Name
Trioxysalen
Englischer Name
TRIOXSALEN
Summenformel
C14H12O3
Molmasse
228.24

Namen und Synonyme

trioxsalen3902-71-4TrioxysalenTrimethylpsoralen4,5',8-TrimethylpsoralenTrioxisalenoTrioxysalene2',4,8-TrimethylpsoralenTrioxysalenumNSC710472,5,9-trimethylfuro[3,2-g]chromen-7-oneTmp (psoralen)
Weitere Namen anzeigen
LACTONENSC-71047TrioxalenTrioxsaleTrixsalenrioxsalenTRISORALENElder 8011
DTXSID3023716NSC 710477H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-Y6UY8OV51T2,5,9-Trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one7H-Furo(3,2-g)(1)benzopyran-7-one, 2,5,9-trimethyl-2,5,9-Trimethyl-7H-furo[3,2-g][1]benzopyran-7-oneDTXCID403716

Datenbank-Bezeichner

CAS
3902-71-4
PubChem CID
5585
DTXSID
DTXSID3023716
ChEMBL
CHEMBL1475
ChEBI
CHEBI:28329
UNII
Y6UY8OV51T
EC Number
223-459-0
Nikkaji
J3.411H

Eigenschaften

Berechnete Struktureigenschaften

XLogP
3
Polarare Oberfläche (TPSA)
39,4 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
0
Schwere Atome
17
Formalladung
0
Komplexität
374

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
SpringerMaterials PropertiesFusion temperature
LogP3.25
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionSolid
Collision Cross Section · 2 Einträge

147.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

146.69 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
229 · 229-231 °C(lit.)
Siedepunkt
310.05 °C · 310.05°C (rough estimate)
Dichte
1.2196 · 1.2196 (rough estimate)
Brechungsindex
1.5557 · 1.5557 (estimate)
storage temp.
-20 °C · -20°C
Löslichkeit
DMSO: soluble
Aggregatzustand
powder
Farbe
white
Merck
14 · 14,9735
BRN
221723 · 221723
InChI
1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
SMILES
Cc1cc2cc3C(C)=CC(=O)Oc3c(C)c2o1
CAS Datenbank
3902 · 3902-71-4
EPA chemische Informationen
7 H-Furo[3,2-g][1]benzopyran-7-one, · 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl- (3902-71-4)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P203, P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P318, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Other Safety InformationIMAP assessments - 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-: Human health tier I assessment
Hazard Classes and CategoriesSkin Corr. 1B (100%)

Toxikologische Informationen

Carcinogen Classification · 5 Einträge

4,5',8-Trimethylpsoralen

Group 3: Not classifiable as to its carcinogenicity to humans

Volume 40: (1986) Some Naturally Occurring and Synthetic Food Components, Furocoumarins and Ultraviolet Radiation

1987

1987

Sicherheitsdaten

F
8-10
wgk
2
tsca
TSCA listed
ridadr
UN 1759 8/PG 1
hs_code
29322985
RTECS-Nr.
LV1576000
risk_code
34-40
hazard_code
C
safety_code
26-36/37/39-45
hazard_class
8
packing_group
III
Speicherklasse
8A - Combustible corrosive hazardous materials
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationEye Dam. 1Muta. 2Skin Corr. 1B

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 4 Einträge

D - Dermatologicals

D - Dermatologicals

QD - Dermatologicals

QD - Dermatologicals

PharmacodynamicsTrioxsalen ispharmacologically inactive but when exposed to ultraviolet radiation or sunlight it is converted to its active metabolite to produce a beneficial reaction affecting the diseased tissue.
Mechanism of ActionAfter photoactivation it creates interstrand cross-links in DNA, which can cause programmed cell death.
FDA Pharmacological Classification · 5 Einträge

Y6UY8OV51T

TRIOXSALEN

Established Pharmacologic Class [EPC] - Psoralen

Chemical Structure [CS] - Psoralens

Trioxsalen is a Psoralen.

MeSH Pharmacological Classification · 1 Eintrag

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.

Cellular LocationsCytoplasm

Verwendung und Herstellung

General Manufacturing Information7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-: INACTIVE

Anwendungen

VerwendenTrioxsalen has been used: to induce small deletion mutations in worms in combination with ultraviolet A (UVA) to induce interstrand crosslinks (ICLs) in DNA for the preparation and photoactivation of trimethyl psoralen

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

EthylacetoacetatEthanolAcetonKaliumcarbonat2-MethylresorcinSulfamidsureMethanolNatriumhydroxidN,N-DiethylanilinMagnesiumsulfat1,2,3-TribrompropanKaliumhydrogensulfatHydrogenchloridNatrium2H-1-Benzopyran-2-one, 7-[(2-chloro-2-propenyl)oxy]-4,8-dimethyl-7-Allyloxy-4,8-dimethyl-chromen-2-one6-allyl-7-hydroxy-4,8-dimethyl-2H-chromen-2-one7-Hydroxy-4,8-dimethylcoumarin
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phot therapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermi .

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 225031
HRID 225031als Produkt
Reaktionsgleichung von HRID 1855734
HRID 1855734als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung